Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-123593
Filing Date
2024-11-07
Accepted
2024-11-07 18:35:54
Documents
2
Period of Report
2024-11-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1531
2 EX-24 ck0002012593-ex24.htm EX-24 14461
  Complete submission text file 0000950170-24-123593.txt   17457
Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address
Silva Paul M (Reporting) CIK: 0001446372 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42121 | Film No.: 241437517

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)